TY  - CONF

T1  - AZD6140, a reversible oral ADP receptor antagonist, does not increase risk of bleeding vs the thienopyridine clopidogrel in patients undergoing CABG surgery in the DISPERSE2 trial

JO  - AMERICAN JOURNAL OF CARDIOLOGY

PY  - 2006/10/22

AU  - Husted S

AU  - Harrington RA

AU  - Cannon CP

AU  - Storey RF

AU  - Wickens M

AU  - Price D

AU  - Emanuelsson H

ED  - 

VL  - 98

IS  - 8A

SP  - 204M

EP  - 204M

Y2  - 2024/12/22

ER  -